B-lymphocyte


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.

B-lymphocyte

a type of LYMPHOCYTE that is formed in the marrow and passed to the lymph glands, producing IMMUNOGLOBULINS (antibodies).

B-cell (B-lymphocyte)

Type of white blood cell that produces antibodies.
Mentioned in: Multiple Myeloma
References in periodicals archive ?
The B-lymphocytes make billions of different types of antibody receptors (B-cells) capable of binding specific antigens and marking them for death.
Most of these cells were EBER positive (Figure 2(c)); B-lymphocytes (CD20+, PAX-5+) were almost absent while there was an expansion of the monocytemacrophage series (CD14+, CD64+).
Rituximab offers effective viral clearance through targeted B-lymphocyte elimination and thus allows temporary treatment of EBV infection in patients with XLP.
Caption: Figure 4: Liver biopsy immunostaining for CD20 (B-lymphocyte marker).
B cell activating factor (BAFF) belongs to the tumor necrosis factor (TNF) family and is also known as B-lymphocyte stimulator (BLyS), TNF and ApoL-related leukocyte-expressed ligand-1 (TALL-1), TNF homologue that activates apoptosis, nuclear factor-[kappa]B, and c-Jun NH2-terminal kinase (THANK), and TNF superfamily member 13B (TNFSF 13B).
For evaluation of antigen recognition in cockatiels, resident lymphoid aggregates in an adjacent, histologically normal section of proventriculus were used as internal control tissue for Tlymphocyte and B-lymphocyte staining.
Characterization of incidentally identified minute clonal B-lymphocyte populations in peripheral blood and bone marrow.
One part is to determine a safe dose of ZQE by gastric perfusion in mice with an acute toxicity and a maximum tolerance test, and the second part of the presented study indicates the immunorestorative effects of ZQE dependent of the doses applied in mice treated with cyclophosphamide, including the carbon clearance index, the weight ratio of immune organ, serum hemolysin, T-, B-lymphocyte transformation rate and IL-2, IFN-, and IL-4 secretion.
The capacity to elicit an effective T- and B-lymphocyte immunity can be shown by the stimulation of lymphocyte proliferation response [17].
Patients with CLL are predisposed to the development of a second malignancy due to impaired immune system chemotherapy or genomic instability.56 CLL status is characterized by progressive impairment in both cell-mediated immunity (B-lymphocyte defects abnormality T-cell number and function natural killer defects) and humoral-mediated immunity (low gamma globulin levels).7 CLL therapeutic modalities especially nucleoside analog therapy make the immunosuppression deeper by involving all elements of the immune system and favoring infectious diseases.
Seronegative Lyme disease--dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi.
PCR assays detect B-lymphocyte clonality in formalinfixed, paraffin-embedded specimens of classical hodgkin lymphoma without microdissection.